このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Single Limb Resistance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) (COPD)

2012年6月19日 更新者:Dr. Karin Wadell、Umeå University

Effects of High-repetitive Single Limb Training on Exercise Capacity and Quality of Life in Patients With COPD Compared to a Control Group - A Prospective, Single Blind, Randomized Controlled Multicenter Trial

The chronic airflow limitation in chronic obstructive pulmonary disease (COPD) patients resulting in increased dyspnea during physical activity restricts many COPD patients ability to perform exercises in general and whole-body exercises in particular. Single limb training performed as one-legged cycling has been shown effective in patients with COPD. This exercise regime results in less stress on the ventilatory system as training is executed using a simultaneously smaller muscle mass. However, the positive physiological effects of exercise training only occur in the involved muscle(s). To be of benefit for patients daily life, all relevant muscles should be included in exercise training. The aim of the current randomized controlled multicenter trial (RCT) is to determine the effects of high-repetitive single limb exercises (HRSLE) in combination with COPD specific patient education, compared to the COPD specific patient education alone in patients with moderate to very severe (stage II-IV) COPD.

調査の概要

詳細な説明

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and mortality in the world. It is one of our most common chronic diseases and up to 700.000 people is estimated to suffer from COPD in Sweden. Exercise intolerance is the key disabling factor in COPD, with decreased exercise capacity, leg fatigue and dyspnea among the most frequently reported symptoms.

Different training modalities have been evaluated to uncover the most effective way of training patients with COPD. Traditionally research has used whole-body, or major muscle mass training regimes when investigating the effect of both endurance and resistance in COPD patients. However recent research have demonstrated positive effects using training regimes involving a simultaneous smaller muscle mass compared to traditional exercise. The concept of using this regime is to put less stress on the ventilator system when exercising to minimize the effect of the chronic airflow limitation and to enhance the ability to be able to exercise for this group of patients compared to traditional training using major muscle mass exercise regimes. Although recent research have shown positive effects of single limb training using one-legged cycling, one major limitation is that only a small amount of important muscles for COPD patients are incorporated. Therefore, the aim of this study is to: (i) examine the effect of a single limb exercise regime on local muscle endurance, maximal strength, quality of life, dyspnea, walking capacity, self-efficacy, anxiety and depression, (ii) to examine if the physiological effects differ between man and women and (iii) to investigate if this exercise regime is feasible and safe to use for patients with COPD.

Patients diagnosed with moderate to very severe COPD according to GOLD criteria will be randomly assigned to constitute either an exercise or control group The exercise group will participate in a high-repetitive single limb exercise regime, consisting of upper and lower limb exercises with elastic resistance, compromised of three sessions per week over a period of 8 weeks. The exercise regime will be performed in group at Umeå University Hospital of Northern Sweden, and at Huddinge University Hospital, Sweden supervised by experienced physiotherapists. Both the exercise and control group will receive four sessions of standardized patient education during the 8 week intervention period. After completion of the study, patients in the control group will be offered participation in the single limb exercise regime.

The most important upper and lower extremity muscles for COPD patients are identified and exercises are designed specific to each of these. The exercise regime consists of 8 exercises, 4 upper extremity and 4 lower extremity exercises. Starting position and performance of the exercises are standardized and the resistance individually adjusted and progressed according to rated dyspnea and muscle fatigue.

Before and after the 8 week intervention period the following information will be collected. Effects on maximal strength, muscular endurance, dyspnea, self-efficacy, anxiety and depression. The relationship between changes in health related variables and changes in exercise capacity, sex related differences in training effects, feasibility of the program, strategies to determine adequate starting resistance and provide accurate resistance for each involved movement and the relationship between muscle fatigue and dyspnea in the different exercise tests will also be analyzed.

研究の種類

介入

入学 (実際)

44

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Huddinge、スウェーデン、141 59
        • Huddinge University Hospital
      • Umeå、スウェーデン、90187
        • Umeå University Hospital

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

40年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  1. Adults 40 years and above.
  2. Stable (no exacerbations within 4 weeks before start of baseline testing) moderate to very severe COPD, stage II-IV, according to GOLD criteria i.e. Forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) < 0.70, FEV1 < 80% predicted.
  3. Ex-smoker.
  4. Stable medical treatment (no changes < 4 weeks before start of baseline testing).
  5. Living less than 60 km from training facility.

Exclusion Criteria:

  1. Musculoskeletal, rheumatic, cardiac or neurological disorders that might affect the exercise performance in training and tests.
  2. Previous lung surgery.
  3. Acute exacerbations of COPD that require a change in pharmacological management within four weeks preceding the start of the intervention
  4. Long-term oxygen treatment.
  5. Participated in organized exercise training, > 2 times a week, within 6 months before start of intervention.
  6. Body mass index (BMI) < 18 kg/m2.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Control group
The control group will receive standardized patient education four times, once every two weeks, during the eight week intervention period.
The control group receives standardized patient education four times, once every two weeks, during the eight week intervention period. Each session will last 60 minutes, consisting of information regarding anatomy, physiology, causes and mechanisms of COPD, drugs, nutrition, aids and energy saving procedures. The information is the same as for the intervention group, given at separate occasions.
実験的:High-repetitive single limb training
The experimental group will receive a high-repetitive single limb exercise regime, three times a week for two months. In addition, the exercise group will receive patient education at four occasions during the intervention period.
The high-repetitive single limb exercise regime consists of three sessions per week during eight weeks of exercise training, giving a total number of 24 sessions at each location (Umeå and Huddinge University hospitals). The exercise sessions are supervised and conducted by a physical therapist using a group format, six to eight participants in each group. Each session will span for 60 minutes, duration of the major components are: 10 min warm-up followed by 40 minutes of single limb training and 10min cool-down. In addition this experimental group also receives four sessions of patient education once every two week.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Quality of life
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
The Swedish Self-Administered Standardized version of the Chronic Respiratory Disease Questionnaire (CRQ-SAS) will be used as primary outcome measure to asses quality of life
Before single limb exercise regime and on completion (at 8 weeks)
Functional lower extremity muscular endurance
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
To asses muscular endurance in the lower extremity the 6-minute walk test will be used as primary outcome measure.
Before single limb exercise regime and on completion (at 8 weeks)
Upper extremity muscular endurance
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
The 6-minute ring and pegboard test will be used as primary outcome measure for upper extremity muscular endurance
Before single limb exercise regime and on completion (at 8 weeks)

二次結果の測定

結果測定
メジャーの説明
時間枠
Isokinetic maximal muscle strength
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Maximal muscle strength in both upper and lower extremity will be evaluated with an isokinetic dynamometer
Before single limb exercise regime and on completion (at 8 weeks)
Upper extremity muscular endurance
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
The Unsupported Upper Limb Exercise test will be used as secondary outcome measure for upper extremtiy muscular endurance
Before single limb exercise regime and on completion (at 8 weeks)
Isokinetic muscular endurance capacity
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Endurance capacity in both upper and lower extremity will be evaluated with an isokinetic dynamometer
Before single limb exercise regime and on completion (at 8 weeks)
Self-efficacy
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Self-efficacy will be evaluated with the exercise self-efficacy scale, and the self-efficacy for walking questionnaire
Before single limb exercise regime and on completion (at 8 weeks)
Anxiety and Depression
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Anxiety and Depression will be evaluated with the hospital anxiety and depression scale (HADs)
Before single limb exercise regime and on completion (at 8 weeks)
Relationship between muscle fatigue and dyspnea in the different exercise tests
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Muscle fatigue and dyspnea will be measured using the BORG CR10 scale during all exercise tests before the start of the study and on completion 8 weeks later. The relationship between ratings of muscle fatigue between tests, dyspnea between tests and the relationship between muscle fatigue rating and dyspnea rating between exercise tests will be investigated.
Before single limb exercise regime and on completion (at 8 weeks)
Develop a strategy to optimize resistance for each involved movement within an exercise regimen
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
The exercises used within the intervention group is performed with elastic resistance. How much the elastic band is stretched for the different exercises is determined by a literature search investigation the strenght relationship between the muscles/movements used in the study. During the study each participant in the intervention group will rate muscle fatigue and dyspnea after each exercise during alla exercise sessions. These rating will be used to develop a strategy to optimize resistance for each involved movement within an exercise regimen
Before single limb exercise regime and on completion (at 8 weeks)
Develop a strategy to minimize attempts needed to determine a multiple repetition resistance using elastic bands
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
55% of the isokinetic peak value obtained during baseline tests will be used to anticipate the 25RM load when using elastic resistance in an attempt to minimize the attempts needed to achieve 25RM.
Before single limb exercise regime and on completion (at 8 weeks)
Determine if this exercise regimen is feasible and safe in stage II-IV COPD patients
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Feasibility will be evaluated through number of participants attendance, adherence and number of participants developing any side effects or injuries during each training session. In addition, compliance to the different parts of the exercise regimen will be evaluated with a standardized questionnaire by both study participants and physiotherapists leading interventions.
Before single limb exercise regime and on completion (at 8 weeks)
Identify if there are any sex related differences in exercise training effects
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
Statistical analyzes will be used to identify if there are any sex related differences in exercise training effects between male and female patients with COPD
Before single limb exercise regime and on completion (at 8 weeks)
Quality-of-life
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
The clinical COPD questionnaire (CCQ) and the SF-36 scale will be used as secondary outcome measures for Quality-of-life
Before single limb exercise regime and on completion (at 8 weeks)
Exercise capacity
時間枠:Before single limb exercise regime and on completion (at 8 weeks)
A constant work rate test investigating the effects on endurance time, ventilatory response, perceived dyspnea and leg fatigue during submaximal cycle test.
Before single limb exercise regime and on completion (at 8 weeks)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Karin Wadell, Ph.D、Umeå University
  • スタディチェア:Andre Nyberg, Msc、Umeå University
  • スタディチェア:Britta Lindström, Ph.D、Umeå University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2011年5月1日

一次修了 (実際)

2012年5月1日

研究の完了 (実際)

2012年6月1日

試験登録日

最初に提出

2011年5月11日

QC基準を満たした最初の提出物

2011年5月13日

最初の投稿 (見積もり)

2011年5月16日

学習記録の更新

投稿された最後の更新 (見積もり)

2012年6月21日

QC基準を満たした最後の更新が送信されました

2012年6月19日

最終確認日

2012年6月1日

詳しくは

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する